Matthew S. Kelly

OverviewAI-generated summary

Matthew S. Kelly's research focuses on infectious diseases, with a particular emphasis on viral infections and the human microbiome. His work has investigated host responses to SARS-CoV-2, including transcriptional dysregulation and the impact of age on infection severity among children and adolescents. Kelly has also explored the durability of neutralizing antibody responses to SARS-CoV-2 in pediatric populations. His research extends to other respiratory viruses, such as Respiratory Syncytial Virus (RSV), with studies evaluating potential vaccine candidates in children.

Beyond viral pathogens, Kelly's group studies bacterial colonization and its associated risk factors, examining the role of non-diphtheriae Corynebacterium species in pneumococcal colonization and investigating potential probiotic candidates like Dolosigranulum pigrum. He also has research interests in the mycobiome, specifically its relation to pancreatic cancer, and has investigated risk factors for Cytomegalovirus (CMV) viremia and treatment-related adverse events in pediatric hematopoietic stem cell transplant recipients. Kelly leads a research group and has a scholarly profile including an h-index of 25, over 131 publications, and 1,950 citations.

Metrics

• h-index: 25
• Publications: 131
• Citations: 1,950